confusion DM should clear up...
..again don't be confused i find DM a very poor public speaker..here is an example, on BNN DM pumped Lipitor and a $14B market (or was it $12B in sales) or summin like that..but as best i know from RVX last presentation is that the PIII is evaluating "high-risk" persons (18.8M person ptoential market) so i assume marketing approval if PIII is successful is limited (by label) to a high-risk group and not the same entire market as Lipitor...now as best i know the FDA takes a very dim view of companies pumping market potential that assumes off label use...and FYI the market value of RVX reflects more the "high-risk" vs the entire Lipitor served market...and FYI no scumbag fraudster like leftcoast would ever post about this issue